Baraclude
Links shared publicly online about this topic
BARACLUDE(R) (entecavir) Approved By The European Commission For The Treatment Of Chronic Hepatitis B In Adult Patients
medicalnewstoday.com — “Bristol-Myers Squibb (NYSE: BMY) announced that BARACLUDE(R) (entecavir) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B (CHB) in adult patients wit” View full resource at medicalnewstoday.com
Most Recently Shared on March 2, 2011 at 12:05 pm By:
BARACLUDE(R) (entecavir) Approved By The European Commission For The Treatment Of Chronic Hepatitis B In Adult Patients http://mnt.to/3RLW
BARACLUDE(R) (Entecavir) Approved By The European Commission For The Treatment Of CHB In Adult Patients With Evidence Of Decompensated Liver Disease
medicalnewstoday.com — “Bristol-Myers Squibb (NYSE:BMY) announced that BARACLUDE® (entecavir) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B (CHB) in adult patients wi” View full resource at medicalnewstoday.com
Most Recently Shared on March 2, 2011 at 9:05 am By:
BARACLUDE(R) (Entecavir) Approved By The European Commission For The Treatment Of CHB In Adult Patients With Evidence ... http://mnt.to/3RKX
Baraclude approved for chronic hepatitis B with decompensated liver disease - ONA
oncologynurseadvisor.com — “Baraclude approved for chronic hepatitis B with decompensated liver disease” View full resource at oncologynurseadvisor.com
Most Recently Shared on October 18, 2010 at 3:14 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Baraclude approved for chronic hepatitis B with decompensated liver disease http://goo.gl/fb/n0M8K
Baraclude approved for chronic hepatitis B with decompensated liver disease - MPR
empr.com — “Baraclude approved for chronic hepatitis B with decompensated liver disease” View full resource at empr.com
Most Recently Shared on October 18, 2010 at 3:08 pm By:
MPR News: Baraclude approved for chronic hepatitis B with decompensated liver disease: Bristol-Myers Squibb announ... http://bit.ly/bu8nO5
Baraclude Sanctioned for Severe Liver Disease - Drugs.com MedNews
drugs.com — “Bristol-Myers Squibb said Monday its liver drug Baraclude (entecavir) has received expanded approval from the U.S. Food and Drug Administration to treat chronic” View full resource at drugs.com
Most Recently Shared on October 19, 2010 at 6:49 am By:
Baraclude Sanctioned for Severe Liver Disease - http://bit.ly/bxQkPt
BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver disease
news-medical.net — “Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) of BARACLUDE for the treatment of chronic hepatitis B (CHB) in adult patients with decompensated liver disease.” View full resource at news-medical.net
Most Recently Shared on October 18, 2010 at 9:19 pm By:
Pregnancy News: BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver diseas... http://bit.ly/c7NTU3
U.S. Food and Drug Administration Approves Baraclude (entecavir) as a Treatment for Chronic Hepatitis B Patients with Evidence of Decompensated Liver Disease
drugs.com — “Baraclude (entecavir) is used for the treatment of chronic hepatitis B. Information from Drugs.com includes Baraclude side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 19, 2010 at 11:11 pm By:
Drugs and Devices OW OW Health
U.S. Food and Drug Administration Approves Baraclude (entecavir) as a Treatment for Chronic Hepatitis B Patie... http://bit.ly/clcQOM #drug
Entecavir Achieves High Response Rate In Real-life Clinical Management Of Patients With Chronic Hepatitis B
medicalnewstoday.com — “The nucleoside analogue entecavir (baraclude, bristol-myers squibb) achieves a high response rate and progressive decline in liver stiffness in patients with chronic hepatitis b, according to res” View full resource at medicalnewstoday.com
Most Recently Shared on November 4, 2009 at 8:25 pm By:
Entecavir Achieves High Response Rate In Real-life Clinical Management Of Patients With Chronic He.. http://bit.ly/3E8wTh #health_news
Medical News: HBV Damage Disappears With Long-Term Therapy - in Gastroenterology, Hepatitis from MedPage Today
medpagetoday.com — “Long-term treatment with entecavir (Baraclude) at least partially reverses cirrhosis and fibrosis in most chronic hepatitis B patients, according to extended follow-up of a clinical trial.” View full resource at medpagetoday.com
Most Recently Shared on August 18, 2010 at 3:41 pm By:
HBV Damage Disappears With Long-Term Therapy (CME/CE) (MedPage Today) -- Long-term treatment with entecavir (Baraclude).. http://dld.bz/suHY
Therapeutics Daily
therapeuticsdaily.com — “Therapeutics Daily” View full resource at therapeuticsdaily.com
Most Recently Shared on March 3, 2011 at 8:14 pm By:
PharmaLive Health News and Pharma
Therapeutics Daily - Baraclude Approved by the European Commission - http://tinyurl.com/4jrotol
HBV Damage Disappears With Long-Term Therapy (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Long-term treatment with entecavir (Baraclude) at least partially reverses cirrhosis and fibrosis in most chronic hepatitis B patients, according to extended follow-up of a clinical trial.” View full resource at qualitypointtech.net
Most Recently Shared on August 18, 2010 at 3:45 pm By:
HBV Damage Disappears With Long-Term Therapy (CME/CE): (MedPage Today) -- Long-term treatment with entecavir (Bara... http://bit.ly/aq6SFm
Entecavir Shows Promise as First-Line Drug for Chronic HBV - QualityPoint Technologies
qualitypointtech.net — “A small group of patients on long term entecavir (Baraclude) for chronic hepatitis B have had lasting viral suppression and regression of advanced cirrhosis, a new report indicates. Reuters Health Information” View full resource at qualitypointtech.net
Most Recently Shared on March 22, 2011 at 4:35 am By:
Entecavir Shows Promise as First-Line Drug for Chronic HBV: A small group of patients on long term entecavir (Bara... http://bit.ly/favWKt
Ranbaxy gets a reprieve in generic case-Pharmaceuticals-Healthcare/Biotech-News By Industry-News-The Economic Times
economictimes.indiatimes.com — “The Delhi High Court has turned down a plea by US pharma major Bristol-Myers Squibb (BMS) to ban India’s Ranbaxy Laboratories from launching a generic, or copycat, version of its patented hepatitis B drug Baraclude.” View full resource at economictimes.indiatimes.com
Most Recently Shared on March 25, 2010 at 1:52 am By:
The Economic Times: Ranbaxy gets a reprieve in generic case in #India. http://bit.ly/cSYjed
New Data on Multiple Bristol-Myers Squibb Compounds to be Presented at AASLD 2010 - Drugs.com MedNews
drugs.com — “Oct 1, 2010 - New data on multiple Bristol-Myers Squibb Company (NYSE BMY) compounds will be presented at the 61st annual meeting of the American Association fo” View full resource at drugs.com
Most Recently Shared on October 1, 2010 at 9:14 pm By:
Drugs and Devices OW OW Health
New Data on Multiple Bristol-Myers Squibb Compounds to be Presented at AASLD 2010: PRINCETON, N.J.--(BUSINESS... http://bit.ly/bkcoCv #drug
Hepatitis B Drug Fights Liver Fibrosis, Cirrhosis
webmd.com — “A new generation of antiviral drugs can help reverse liver fibrosis and even early cirrhosis in patients with chronic hepatitis B virus infection, and they continue to work for many years, new research suggests.” View full resource at webmd.com
Most Recently Shared on August 18, 2010 at 11:47 pm By:
Hepatitis B Drug Fights Liver Fibrosis, Cirrhosis: A new generation of antiviral drugs can help reverse liver fibr... http://bit.ly/dyeCJB
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MNT Liver Disease
The latest liver disease / hepatitis news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Liver Disease
The latest liver disease / hepatitis news published daily. Articles from research centers, universities and prestigious journals.
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
Advertisement
